• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经肺部序贯给予 siRNA 和 pDNA 干粉建立基因沉默评估方法:裸 siRNA 吸入干粉可抑制肺部荧光素酶基因表达。

Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung.

机构信息

Department of Drug Delivery Research, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.

Department of Drug Delivery Research, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.

出版信息

J Pharm Sci. 2019 Aug;108(8):2661-2667. doi: 10.1016/j.xphs.2019.03.029. Epub 2019 Apr 5.

DOI:10.1016/j.xphs.2019.03.029
PMID:30954524
Abstract

In order to evaluate the in vivo effect of inhaled formulations, it is a gold standard to create a lung metastasis model by intravenously injecting cancer cells into an animal. Because the cancer grows from the blood vessel side, there is a possibility of underestimating the effect of an inhaled formulation administered to the lung epithelium side. In addition, the metastasis model has disadvantages in terms of preparation time and expense. The present study aimed to establish a new method to evaluate the effect of an inhaled small interfering RNA (siRNA) formulation that is more correct, more rapid, and less expensive. We investigated whether siRNA can suppress gene expression of plasmid DNA (pDNA) by serial pulmonary administration of siRNA and pDNA powders prepared by spray-freeze-drying. We revealed that formulations of dry siRNA powder significantly suppressed gene expression of pDNA powder compared with a control group with no siRNA. Naked siRNA inhalation powder with no vector showed the suppression of gene expression equivalent to that of an siRNA-polyethyleneimine complex without damaging tissues. These results show that the present method is suitable for evaluating the gene-silencing effect of inhaled siRNA powders.

摘要

为了评估吸入制剂的体内效果,通过将癌细胞静脉注射到动物体内来创建肺转移模型是金标准。因为癌症从血管侧生长,所以有可能低估施用于肺上皮侧的吸入制剂的效果。此外,转移模型在制备时间和费用方面存在缺点。本研究旨在建立一种更正确、更快速、更经济的评估吸入小干扰 RNA(siRNA)制剂效果的新方法。我们研究了通过连续肺部给予 siRNA 和通过喷雾冷冻干燥制备的 pDNA 粉末,siRNA 是否可以抑制质粒 DNA(pDNA)的基因表达。我们揭示了与没有 siRNA 的对照组相比,干燥的 siRNA 粉末制剂显著抑制了 pDNA 粉末的基因表达。没有载体的裸露 siRNA 吸入粉末显示出与不损伤组织的 siRNA-聚亚乙基亚胺复合物相当的基因表达抑制。这些结果表明,本方法适用于评估吸入 siRNA 粉末的基因沉默效果。

相似文献

1
Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung.经肺部序贯给予 siRNA 和 pDNA 干粉建立基因沉默评估方法:裸 siRNA 吸入干粉可抑制肺部荧光素酶基因表达。
J Pharm Sci. 2019 Aug;108(8):2661-2667. doi: 10.1016/j.xphs.2019.03.029. Epub 2019 Apr 5.
2
Naked pDNA/hyaluronic acid powder shows excellent long-term storage stability and gene expression in murine lungs.裸 DNA/透明质酸粉末在小鼠肺部显示出优异的长期储存稳定性和基因表达。
Int J Pharm. 2020 Jan 25;574:118880. doi: 10.1016/j.ijpharm.2019.118880. Epub 2019 Dec 4.
3
Naked pDNA Inhalation Powder Composed of Hyaluronic Acid Exhibits High Gene Expression in the Lungs.透明质酸裸 pDNA 吸入粉在肺部具有高基因表达。
Mol Pharm. 2019 Feb 4;16(2):489-497. doi: 10.1021/acs.molpharmaceut.8b00502. Epub 2019 Jan 7.
4
Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.喷雾冷冻干燥 siRNA/PEI 粉末的研制及其用于吸入的高气溶胶性能和强大的肺部基因沉默活性。
J Control Release. 2018 Jun 10;279:99-113. doi: 10.1016/j.jconrel.2018.04.003. Epub 2018 Apr 6.
5
Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.喷雾冷冻干燥粉末吸入法优化小鼠肺部基因转染。
J Control Release. 2010 Jun 1;144(2):221-6. doi: 10.1016/j.jconrel.2010.02.018. Epub 2010 Feb 22.
6
Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.使用喷雾干燥技术并以L-亮氨酸作为分散增强剂的裸露小干扰RNA吸入粉末制剂。
Int J Pharm. 2017 Sep 15;530(1-2):40-52. doi: 10.1016/j.ijpharm.2017.07.013. Epub 2017 Jul 15.
7
Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation.用于吸入的质粒DNA和小干扰RNA的干粉制剂
Curr Pharm Des. 2015;21(27):3854-66. doi: 10.2174/1381612821666150820105916.
8
Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.采用双流喷嘴喷雾冷冻干燥法制备吸入用裸 siRNA 的多孔粉末制剂。
Int J Pharm. 2018 Dec 1;552(1-2):67-75. doi: 10.1016/j.ijpharm.2018.09.045. Epub 2018 Sep 19.
9
Stability of Naked Nucleic Acids under Physical Treatment and Powder Formation: Suitability for Development as Dry Powder Formulations for Inhalation.物理处理及粉末形成过程中裸核酸的稳定性:作为吸入用干粉制剂开发的适用性
Pharmaceutics. 2023 Dec 16;15(12):2786. doi: 10.3390/pharmaceutics15122786.
10
Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.具有抗H1N1流感病毒活性的siRNA和pH响应性肽的可吸入干粉制剂。
Mol Pharm. 2015 Mar 2;12(3):910-21. doi: 10.1021/mp500745v. Epub 2015 Jan 30.

引用本文的文献

1
Approaches and applications in transdermal and transpulmonary gene drug delivery.经皮和经肺基因药物递送的方法与应用
Front Bioeng Biotechnol. 2025 Jan 15;12:1519557. doi: 10.3389/fbioe.2024.1519557. eCollection 2024.
2
Inhalable Dry Powders for Lung mRNA Delivery.可吸入干粉用于肺部 mRNA 递药。
Adv Healthc Mater. 2024 Nov;13(29):e2400509. doi: 10.1002/adhm.202400509. Epub 2024 Oct 1.
3
Tiny Guides, Big Impact: Focus on the Opportunities and Challenges of miR-Based Treatments for ARDS.微小指南,重大影响:聚焦基于微小RNA治疗急性呼吸窘迫综合征的机遇与挑战。
Int J Mol Sci. 2024 Feb 28;25(5):2812. doi: 10.3390/ijms25052812.
4
p53 dry gene powder enhances anti-cancer effects of chemotherapy against malignant pleural mesothelioma.p53 干燥基因粉末增强了化疗对恶性胸膜间皮瘤的抗癌效果。
Gene Ther. 2024 Mar;31(3-4):119-127. doi: 10.1038/s41434-023-00424-y. Epub 2023 Oct 13.
5
Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.喷雾冷冻干燥生物制剂:综述及吸入给药应用。
Pharm Res. 2023 May;40(5):1115-1140. doi: 10.1007/s11095-022-03442-4. Epub 2022 Dec 1.
6
Development and application of ribonucleic acid therapy strategies against COVID-19.针对 COVID-19 的核糖核酸治疗策略的开发和应用。
Int J Biol Sci. 2022 Aug 1;18(13):5070-5085. doi: 10.7150/ijbs.72706. eCollection 2022.
7
Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery.细胞穿透肽:用于mRNA递送的新兴工具
Pharmaceutics. 2021 Dec 29;14(1):78. doi: 10.3390/pharmaceutics14010078.
8
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.用于阻塞性气道疾病的吸入式RNA疗法:最新进展与未来前景
Pharmaceutics. 2021 Jan 28;13(2):177. doi: 10.3390/pharmaceutics13020177.
9
Inhaled RNA Therapy: From Promise to Reality.吸入式 RNA 疗法:从承诺到现实。
Trends Pharmacol Sci. 2020 Oct;41(10):715-729. doi: 10.1016/j.tips.2020.08.002. Epub 2020 Sep 4.
10
Prospects for RNAi Therapy of COVID-19.新冠病毒病的RNA干扰疗法前景
Front Bioeng Biotechnol. 2020 Jul 30;8:916. doi: 10.3389/fbioe.2020.00916. eCollection 2020.